Iranian Journal of Pediatrics

Published by: Kowsar

Selective Screening for Inborn Errors of Metabolism: A Report of Six Years Experience

Esra Dogan 1 , Sezer Uysal 1 , * , Yesim Ozturk 2 , Nur Arslan 2 and Canan Coker 1
Authors Information
1 Dokuz Eylul University, Faculty of Medicine, Department of Biochemistry, Izmir, Turkey
2 Dokuz Eylul University, Faculty of Medicine, Department of Pediatrics, Division of Pediatric Gastroenterology, Nutrition and Metabolism, Izmir, Turkey
Article information
  • Iranian Journal of Pediatrics: October 2017, 27 (5); e11323
  • Published Online: October 16, 2017
  • Article Type: Research Article
  • Received: March 5, 2017
  • Revised: July 4, 2017
  • Accepted: July 29, 2017
  • DOI: 10.5812/ijp.11323

To Cite: Dogan E, Uysal S, Ozturk Y, Arslan N, Coker C. Selective Screening for Inborn Errors of Metabolism: A Report of Six Years Experience, Iran J Pediatr. 2017 ; 27(5):e11323. doi: 10.5812/ijp.11323.

Copyright © 2017, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Golbahar J, Al-Jishi EA, Altayab DD, Carreon E, Bakhiet M, Alkhayyat H. Selective newborn screening of inborn errors of amino acids, organic acids and fatty acids metabolism in the Kingdom of Bahrain. Mol Genet Metab. 2013; 110(1-2): 98-101[DOI][PubMed]
  • 2. Frazier DM, Millington DS, McCandless SE, Koeberl DD, Weavil SD, Chaing SH, et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis. 2006; 29(1): 76-85[DOI][PubMed]
  • 3. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem. 2001; 47(11): 1945-55[PubMed]
  • 4. Feuchtbaum L, Lorey F, Faulkner L, Sherwin J, Currier R, Bhandal A, et al. California's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry. Pediatrics. 2006; 117(5 Pt 2)-9[DOI][PubMed]
  • 5. Vilarinho L, Rocha H, Sousa C, Marcao A, Fonseca H, Bogas M, et al. Four years of expanded newborn screening in Portugal with tandem mass spectrometry. J Inherit Metab Dis. 2010; 33 Suppl 3-8[DOI][PubMed]
  • 6. Scolamiero E, Cozzolino C, Albano L, Ansalone A, Caterino M, Corbo G, et al. Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism. Mol Biosyst. 2015; 11(6): 1525-35[DOI][PubMed]
  • 7. McHugh D, Cameron CA, Abdenur JE, Abdulrahman M, Adair O, Al Nuaimi SA, et al. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med. 2011; 13(3): 230-54[DOI][PubMed]
  • 8. Marquardt G, Currier R, McHugh DM, Gavrilov D, Magera MJ, Matern D, et al. Enhanced interpretation of newborn screening results without analyte cutoff values. Genet Med. 2012; 14(7): 648-55[DOI][PubMed]
  • 9. Sun W, Wang Y, Yang Y, Wang J, Cao Y, Luo F, et al. The screening of inborn errors of metabolism in sick Chinese infants by tandem mass spectrometry and gas chromatography/mass spectrometry. Clin Chim Acta. 2011; 412(13-14): 1270-4[DOI][PubMed]
  • 10. Han LS, Ye J, Qiu WJ, Gao XL, Wang Y, Gu XF. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report. J Inherit Metab Dis. 2007; 30(4): 507-14[DOI][PubMed]
  • 11. Selim LA, Hassan SA, Salem F, Orabi A, Hassan FA, El-Mougy F, et al. Selective screening for inborn errors of metabolism by tandem mass spectrometry in Egyptian children: a 5 year report. Clin Biochem. 2014; 47(9): 823-8[DOI][PubMed]
  • 12. Han L, Han F, Ye J, Qiu W, Zhang H, Gao X, et al. Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry. J Clin Lab Anal. 2015; 29(2): 162-8[DOI][PubMed]
  • 13. Nagaraja D, Mamatha SN, De T, Christopher R. Screening for inborn errors of metabolism using automated electrospray tandem mass spectrometry: study in high-risk Indian population. Clin Biochem. 2010; 43(6): 581-8[DOI][PubMed]
  • 14. Alfadhel M, Benmeakel M, Hossain MA, Al Mutairi F, Al Othaim A, Alfares AA, et al. Thirteen year retrospective review of the spectrum of inborn errors of metabolism presenting in a tertiary center in Saudi Arabia. Orphanet J Rare Dis. 2016; 11(1): 126[DOI][PubMed]
  • 15. Chen B, Mei J, Kalman L, Shahangian S, Williams I, Gagnon M, et al. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. Morbid Mortal Weekly Rep Recommend Rep. 2012; 61(2): 1-44
  • 16. Hassan FA, El-Mougy F, Sharaf SA, Mandour I, Morgan MF, Selim LA, et al. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study. J Med Screen. 2016; 23(3): 124-9[DOI][PubMed]
  • 17. Al Riyami S, Al Maney M, Joshi SN, Bayoumi R. Detection of Inborn Errors of Metabolism using Tandem Mass Spectrometry among High-risk Omani Patients. Oman Med J. 2012; 27(6): 482-5[DOI][PubMed]
  • 18. Yoon HR, Lee KR, Kang S, Lee DH, Yoo HW, Min WK, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Chim Acta. 2005; 354(1-2): 167-80[DOI][PubMed]
  • 19. Dionisi-Vici C, Deodato F, Roschinger W, Rhead W, Wilcken B. 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis. 2006; 29(2-3): 383-9[DOI][PubMed]
  • 20. de Sain-van der Velden MG, Diekman EF, Jans JJ, van der Ham M, Prinsen BH, Visser G, et al. Differences between acylcarnitine profiles in plasma and bloodspots. Mol Genet Metab. 2013; 110(1-2): 116-21[DOI][PubMed]
  • 21. Van Hove JL, Kahler SG, Feezor MD, Ramakrishna JP, Hart P, Treem WR, et al. Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency. J Inherit Metab Dis. 2000; 23(6): 571-82[PubMed]
  • 22. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory, Approved Guideline, CLSI Document EP28-A3c. 2008;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments